For some people it can feel worse for a while, and the trials have not shown that lasting. People with PTSD describe traumatic memories surfacing during a ketamine session, and anxiety and a shaken few days afterwards. In the three main controlled trials of ketamine for PTSD, symptoms on ketamine ended lower than on the comparison drug, or about the same, and in the trials that measured it, the dissociation from the dose wore off within hours (Feder, 2014 and 2021; Abdallah, 2022). At Hive Bio, a doctor and a nurse are with you throughout each session, and a therapist works with you in the days after it.
In people’s accounts, the hardest stretches are the hours spent alone with what surfaced, often at home the same evening. That is the part you can plan for.
Can ketamine make PTSD worse?
Two questions hide inside that one, and the answers differ. Can a session leave you shaken for days? Can a course leave PTSD worse than it was before you started?
The accounts below come from people writing on public ketamine forums, read in September 2026. They are stories rather than a count: people whose course went smoothly write about it less often, so none of this says how often a flare happens.
The short-term flare is real and people describe it plainly. “I am taking ketamine for PTSD,” one person wrote after a hard second session. “I thought ketamine was supposed to make me feel better, not worse.”
Over a whole course the better guide is the controlled trials, and what they measured is set out further down this page. A flare after a session is possible and worth planning for. Before you start, write down what a bad few days would look like for you and who you would tell on the first of them; what to raise before a first ketamine session covers the rest of that list. Whether ketamine is a sensible step for your PTSD is a question about your history. It is answered at a medical assessment with two doctors.
In the hard accounts, the person was left alone with what surfaced
People with PTSD describe what comes up in a few ways. One person, after a higher dose, wrote that the session turned into a giant looping flashback of a really traumatic event. Another, after a first infusion during PTSD treatment, described looping paranoia and intense shame that took over the session.
One family member asked whether a relative had had therapy at all: “Was it PTSD therapy or just being given ketamine?” The relative had gone through sessions that kept revisiting his trauma, and came out worse, with little preparation for what might surface and little help making sense of it afterwards.
The hard stories follow that pattern. What came up stayed unworked, and the evening went by at home with it. Others describe a dip that turned: “I did feel worse before I felt better,” one person wrote after a long course.
These accounts cannot say how the smoother courses were run, because those get written about less often. Who is with you in the days after a session is still worth settling before you start, and it is one of the things the first call with our team covers.
What studies show
Ketamine is studied for PTSD to see whether it can lower symptoms quickly, and two controlled trials found that it did so more than the comparison drug (Feder and colleagues, 2014 and 2021). The trials are few and small, they ran for weeks, and their results differ from trial to trial.
- Feder and colleagues, 2014 (JAMA Psychiatry): 41 people, one infusion against midazolam, PTSD symptoms measured at 24 hours. Ketamine lowered PTSD scores more at 24 hours.
- Feder and colleagues, 2021 (American Journal of Psychiatry): 30 people, six infusions over two weeks. 67% responded on ketamine, meaning their symptom scores fell by a set threshold, against 20% on midazolam, and among those who responded the benefit lasted a median of 27.5 days after the last infusion. No serious adverse events.
- Abdallah and colleagues, 2022 (Neuropsychopharmacology): 158 veterans and service members whose PTSD had not responded to earlier medication, eight infusions over four weeks, followed for four weeks after. No difference from placebo on PTSD symptoms; people were no more likely to stop the trial early on ketamine.
A 2026 systematic review pooled seven randomised trials with 323 participants in total and found clear improvement in two of them (Yin and colleagues, Acta Psychiatrica Scandinavica). Across those trials a course of several infusions did more than a single dose, and on preliminary evidence repeated lower doses held the effect longer than the standard one. Follow-up in these trials lasted a matter of weeks, so there is no trial data yet on how people are a year on, and the plan for the months after a course is worth thinking through before it starts.
For PTSD, a clinician reads these results like this:
Studied in small randomised trials with mixed results: some show symptom reduction, others no advantage over an active control. Trauma-focused psychotherapy remains first-line, and ketamine is used alongside it rather than instead of it. Timing carries the most weight here, because working with trauma at the wrong moment can destabilise: this is a judgement to make with a therapist who knows the ground, not one to reach alone.
Checked for medical accuracy by Dr Christopher Gauci, MD MRCS(Ed) EDAIC on 9 November 2026. The check covers this section. Everything else on the page is written by our editorial team and verified against primary sources.
What the PTSD trials measured
- 7 trials, 323 people. Clear improvement in two of the seven (Yin, 2026)
- 158 veterans, eight infusions. No difference from placebo; dissociation gone within two hours (Abdallah, 2022)
- 41 people, one infusion. Lower PTSD scores than midazolam at 24 hours (Feder, 2014)
- 30 people, six infusions. 67% responded against 20% on midazolam; benefit lasted a median of 27.5 days (Feder, 2021)
Timing is the part of this that gets decided for each person, and it is decided at the medical assessment with two doctors, from what happened to you and what you have already tried. Both are worth writing down beforehand, with dates where you have them.
Who is at higher risk
Two groups stand out, and the one most people arrive here with is PTSD that comes with heavy dissociation. On that the trials behind this page carry no finding either way: none of them set out to test dissociation as a risk factor, and Feder and colleagues (2014) recorded no clinically significant persistent dissociative symptoms in the people they treated. It is weighed for each person instead, and dissociative disorders and PTSD with prominent dissociation sit on the list a psychiatrist weighs for each person separately. Before you speak to a psychiatrist, write down how your dissociation shows up, how often, and what brings you back.
The second group is people given ketamine in the first hours after a trauma for pain rather than as treatment later. In a small study of 50 accident victims, 13 of whom had ketamine, ketamine given during emergency care went with more acute stress symptoms three days on (Schönenberg and colleagues, 2008, Journal of Psychopharmacology), while ketamine inside the anaesthetic for later surgery went with less PTSD, 27% against 46%, a result the authors call contrary to expectations (McGhee and colleagues, 2008, Journal of Trauma). Neither moment is ketamine as a treatment for PTSD later in life.
The list a psychiatrist works from has two parts:
Ketamine treatment is a newer therapeutic tool, and who it suits is settled by assessment rather than by reading a list. The assessment has two parts, and a service that runs only one of them, or neither, is not screening you. Most of what comes up in it is worked with rather than ruled out.
The physical assessment checks how your body will handle the short rise in blood pressure and heart rate that follows a dose. For most people that passes without incident. A small number of conditions make it unsafe: an aneurysm or arteriovenous malformation, a history of bleeding in the brain, a recent heart attack or stroke, a known allergy to ketamine, or anything else where a brief rise in blood pressure carries serious risk.
More often the assessment finds something that changes the plan rather than ending it. Conditions in this group:
- uncontrolled high blood pressure
- significant heart or lung disease
- liver problems
- raised pressure inside the skull or the eye
- past bladder problems linked to ketamine
- pregnancy and breastfeeding
- an overactive thyroid that is not under control
Our programme does not treat anyone under 18.
The psychiatric assessment looks at whether the experience itself is safe for you right now. Ketamine produces altered perception and dissociation by design, and a small number of states make that unsafe: active psychosis, a diagnosis of schizophrenia, or a manic episode of bipolar disorder. Timing matters here more than in the physical assessment, and an answer of not now is different from an answer of never.
A current, untreated substance use disorder, particularly one involving ketamine or other dissociatives, is addressed first rather than alongside, because ketamine carries recognised potential for misuse.
Absolute exclusions (common across clinical protocols)
- Current or past psychotic disorder: schizophrenia, schizoaffective disorder, delusional disorder, or psychotic features during a mood episode.
- Current mania or hypomania, or bipolar I with a recent manic episode.
- Active substance use disorder, especially involving ketamine, PCP or other dissociatives, stimulants, or moderate-to-severe alcohol use.
- Acute suicidal risk (a current plan or intent) that needs inpatient care rather than an outpatient or retreat setting.
- Delirium, dementia or significant cognitive impairment.
- Inability to give informed consent.
Relative exclusions (need a psychiatrist’s judgement case by case)
- A first-degree relative with a psychotic disorder. Many trials treat this as an absolute exclusion.
- Bipolar II, or bipolar I that is stable on a mood stabiliser.
- Borderline personality disorder with recent self-harm or marked instability.
- Dissociative disorders (DID or severe depersonalisation), and PTSD with prominent dissociation.
- Severe eating disorder, especially anorexia that isn’t medically stable.
- A history of ketamine misuse, even if it is now in remission.
- A history of severe adverse reactions to psychedelics or dissociatives.
Medications to flag (they don’t exclude, but they change the protocol)
- Benzodiazepines and lamotrigine blunt ketamine’s effect.
- Stimulants and MAOIs add blood-pressure risk.
- Opioids and other CNS depressants increase sedation and breathing risk.
A real assessment covers medical and psychiatric history, current medication, substance use, heart health, and a clear account of previous treatment. It is a conversation with a clinician, not a form to score yourself against: the same fact means different things depending on everything else in the picture.
Checked for medical accuracy by Dr Christopher Gauci, MD MRCS(Ed) EDAIC on 9 November 2026. The check covers this section. Everything else on the page is written by our editorial team and verified against primary sources.
Unsure which side of that list your own trauma history falls on? The short form and a call start the process, and two doctors tell you whether it fits before you pay for the programme.
Preparation and integration as protection
Support for what surfaces starts before the first dose and continues through the days after each one, and that holds whether the sessions happen near home or inside a residential week.
Preparation. You talk through what might surface in a session and agree in advance what you will do if it does. It also means grounding: calming and steadying practices you try out before the first dose.
Someone to bring it to afterwards. Trauma that comes up in a session is worked with one to one rather than carried home alone. Ask who does that on the service you are considering, and on which days they are free.
Integration after each session. In the days straight after a session, while what came up is still close, you write about it, talk it through and do gentle movement, and how integration works after a psychedelic session has its own page.
How much therapy belongs around the sessions is not a number the trials have settled. A 2026 analysis pooled 12 studies of people who had ketamine alongside psychotherapy for PTSD and found greater improvement with more psychotherapy sessions, but most of those studies were rated poor quality, and on the better ones alone the link with session count no longer held (Rohde and colleagues, Psychotherapy and Psychosomatics). The therapy around the sessions is how we build the week.
For a first course, you can book a 15-minute call with our team and ask how the preparation weeks run before anyone sets dates.
What to do if it gets worse
If you have a bad day or two after a session, these are simple things to do.
- Say it out loud. Tell the therapist or the treating team what came up, even if it feels small.
- Write it down. A few lines about the memory, the feeling or the dream, while it is still close. It gives the next conversation something to start from.
- Use the grounding you prepared. A walk, slow breathing, something warm to hold. The aim is to stay in the present while the wave passes.
- Keep alcohol and other substances out of it. Ask the treating team before you take anything else.
- Do not change your medication on your own. Anything you take for sleep or anxiety goes through the prescriber.
Some changes are a reason to contact the team before the next session rather than wait: anxiety or memories that keep climbing over several days instead of settling, sleep badly disturbed for several nights, or distress that frightens you. If you are not under a treating team right now, that call goes to your own doctor. If you are thinking about harming yourself, get help straight away rather than at the next appointment: the treating team if you can reach them, and if you cannot, call 112 in Malta or elsewhere in the EU, 999 in the UK, or go to the nearest emergency department.
The same applies once a course is over, when the team that dosed you is no longer around. The benefit measured in the trials was counted in weeks rather than years (Feder, 2021), so who you contact afterwards is worth agreeing before the first session, and you can ask our team how that works on the programme.
How trauma work is held on our programme
On an outpatient course, the evening after an infusion is usually spent at home, so it matters who you can reach that evening. On our residential programme on Gozo, the days after each session are part of the treatment.
What you get here is a therapist who has already met you in preparation and works with you one to one in the days after each session, while what came up is still close. Someone from the Hive team is in the house day and night, with emergency contacts to hand, and if the doctor has any concern about how you are after a session, a nurse stays the night; otherwise the doctor and the nurse are not usually in the house overnight. Four guests at most, each in a single room, and the same three clinicians, Dr Christopher Gauci, Dr Peter Muscat and psychotherapist Audra Micallef, for the whole week.
If structured trauma-focused therapy is part of what you are looking for, say so on the 15-minute call: the team can tell you how the therapy days in your week would be built. What happens in each of the three phases is set out on the programme page.
Three ways to start, one medical team
3 weeks · Malta, outpatient
A course of infusions
Six IV infusions over three weeks, two a week, at our partner clinic in Malta. A doctor gives and watches every infusion. No GP referral needed.
7 weeks · online and Malta
The seven-week programme
Three weeks of preparation online, one week in a house in Malta with ketamine-assisted sessions and therapy, then three weeks of integration from home. Four guests at a time.
7 weeks · private
The private retreat
The same seven weeks, with the house and the team to yourself for your week in Malta.
Bringing trauma to treatment?
Tell us what you have tried for PTSD. A psychiatrist reads it and confirms what suits you, a course of infusions or the seven-week programme with trauma-focused therapy, before you pay for treatment.
No payment and no booking at this step.
Common questions
Is ketamine good for PTSD?
The results are mixed, and the figures sit in the trials section above: improvement in some of the randomised trials, none in the largest one (Yin, 2026; Abdallah, 2022). In that largest trial the standard dose still lowered depression scores more than placebo, which is part of why ketamine is offered when PTSD and depression run together (Abdallah, 2022). What differs between the courses people describe is how much support sat around the sessions. How the week in Malta is built shows what that looks like when it is planned in.
Can ketamine bring out repressed memories?
People do describe memories surfacing during or after a session, sometimes ones they had not thought about for years. A memory that surfaces under ketamine is worth working through with a therapist rather than alone with it. Memories recalled in an altered state are not always accurate, so they are worked through as experience rather than taken as a record of what happened, and big decisions based on them wait until after the course. If this is the part that worries you, write down now who you would speak to on the day it happened, and ask whoever would be dosing you who holds that conversation on their service.
If you are considering ketamine for PTSD, plan the days after a session, not only the session itself. Agree before you start who you will tell if memories or anxiety climb, and make sure that person is reachable in the evenings. A hard few days after a session is what those accounts describe; lasting worsening is not what the controlled trials found (Feder, 2014 and 2021; Abdallah, 2022).